Platelet-derived growth factor. I. High yield purification and evidence for multiple forms - PubMed (original) (raw)

. 1982 May 10;257(9):5154-60.

PMID: 7068680

Free article

Platelet-derived growth factor. I. High yield purification and evidence for multiple forms

E W Raines et al. J Biol Chem. 1982.

Free article

Abstract

Platelet-derived growth factor has been purified from human outdated platelet-rich plasma with a 21% overall yield. This five-step procedure represents a 500,000-fold purification over serum. 6.4 ng/ml (2 X 10(-10) M) of purified platelet-derived growth factor stimulated DNA synthesis in quiescent, density arrested cultures of Swiss 3T3 cells to a level equivalent to that produced by 5% calf serum. The growth-promoting activity and specific binding to 3T3 cells has been shown to be associated with four entities of molecular weights: 31,000, 29,000, 28,500, and 27,000, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis under nonreducing conditions. In the presence of 2-mercaptoethanol, the four molecular species are converted to three inactive chains of lower molecular weights: 17,500, 16,000, and 14,400. Other methods of chemically cleaving the disulfide bonds were investigated: reductive cleavage by S-sulfonation, reductive cleavage with dithiothreitol, and performic acid oxidation. In all cases, mitogenic activity was reduced by 80-100%. Attempts to restore mitogenic activity after reduction were unsuccessful. Two-dimensional 125I-peptide mapping of the nonreduced and reduced multiple forms was also investigated. The four nonreduced moieties gave basically identical maps. The maps of the reduced 17,500- and 16,000-dalton chains were also essentially identical, but the map of the reduced 14,400-dalton chain was significantly different. We propose that platelet-derived growth factor consists of two polypeptide chains: a 14,400-dalton chain and either a 17,500- or a 16,000-dalton chain.

PubMed Disclaimer

Cited by

The History and Current Status of Platelet-Rich Plasma Therapy in Dermatology.
Rodriguez M, Mayrovitz HN. Rodriguez M, et al. Cureus. 2024 Aug 31;16(8):e68306. doi: 10.7759/cureus.68306. eCollection 2024 Aug. Cureus. 2024. PMID: 39350861 Free PMC article. Review.
Freeze-Dried Platelet-Rich Plasma Induces Osteoblast Proliferation via Platelet-Derived Growth Factor Receptor-Mediated Signal Transduction.
Kinoshita H, Orita S, Inage K, Fujimoto K, Shiga Y, Abe K, Inoue M, Norimoto M, Umimura T, Ishii T, Yonemoto T, Kamoda H, Tsukanishi T, Suzuki M, Hirosawa N, Akazawa T, Ohtori S. Kinoshita H, et al. Asian Spine J. 2020 Jan;14(1):1-8. doi: 10.31616/asj.2019.0048. Epub 2019 Oct 4. Asian Spine J. 2020. PMID: 31575111 Free PMC article.
Freeze-Dried Human Platelet-Rich Plasma Retains Activation and Growth Factor Expression after an Eight-Week Preservation Period.
Shiga Y, Kubota G, Orita S, Inage K, Kamoda H, Yamashita M, Iseki T, Ito M, Yamauchi K, Eguchi Y, Sainoh T, Sato J, Fujimoto K, Abe K, Kanamoto H, Inoue M, Kinoshita H, Furuya T, Koda M, Aoki Y, Toyone T, Takahashi K, Ohtori S. Shiga Y, et al. Asian Spine J. 2017 Jun;11(3):329-336. doi: 10.4184/asj.2017.11.3.329. Epub 2017 Jun 15. Asian Spine J. 2017. PMID: 28670400 Free PMC article.
Chitosan scaffold enhances growth factor release in wound healing in von Willebrand disease.
Periayah MH, Halim AS, Saad AZ, Yaacob NS, Hussein AR, Karim FA, Rashid AH, Ujang Z. Periayah MH, et al. Int J Clin Exp Med. 2015 Sep 15;8(9):15611-20. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26629055 Free PMC article.
Inhibition of proliferation and migration of luminal and claudin-low breast cancer cells by PDGFR inhibitors.
Stalker L, Pemberton J, Moorehead RA. Stalker L, et al. Cancer Cell Int. 2014 Sep 5;14(1):89. doi: 10.1186/s12935-014-0089-5. eCollection 2014. Cancer Cell Int. 2014. PMID: 25253994 Free PMC article.

Platelet-derived growth factor. I. High yield purification and evidence for multiple forms - PubMed (original) (raw)